Kotaro Hayashi Selected Research

Kotaro Hayashi Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 09/2014
9	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2022 - 09/2019
7	Atopic Dermatitis (Atopic Eczema) 09/2021 - 06/2019
3	Inflammation (Inflammations) 01/2021 - 02/2020
2	Alopecia Areata 09/2021 - 06/2019
2	Dermatitis 02/2020 - 09/2019
2	Psoriatic Arthritis 02/2020 - 01/2020
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2016 - 09/2014
1	COVID-19 06/2022
1	Fever (Fevers) 05/2021
1	Melanoma (Melanoma, Malignant) 05/2021
1	Herpes Zoster 04/2021
1	Neuralgia (Stump Neuralgia) 04/2021
1	Abscess 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Eczema 09/2020
1	Conjunctivitis 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 11/2019
1	Breast Neoplasms (Breast Cancer) 10/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2018
1	Glaucoma 11/2018
1	Sarcoidosis (Schaumann Disease) 08/2018
1	Rheumatoid Arthritis 08/2018
1	Blister (Bulla) 05/2018
1	Bullous Pemphigoid (Pemphigoid) 05/2018
1	Fibrosis (Cirrhosis) 04/2018
1	Phlebitis 04/2018
1	Skin Diseases (Skin Disease) 04/2018
1	Immunoglobulin G4-Related Disease 04/2018
1	Papilloma (Papillomatosis) 12/2016

Drug/Important Bio-Agent (IBA)

6	Small Interfering RNA (siRNA)IBA 01/2021 - 09/2014
5	dupilumabIBA 02/2021 - 06/2019
4	GoldIBA 01/2022 - 09/2014
3	Messenger RNA (mRNA)IBA 08/2020 - 11/2018
2	ixekizumabIBA 11/2022 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 04/2021 - 09/2019
2	Biomarkers (Surrogate Marker)IBA 04/2021 - 10/2020
2	Chemokine CCL17IBA 10/2020 - 01/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2020 - 01/2014
2	Ointments (Pastes)IBA 02/2020 - 01/2014
2	Imiquimod (Aldara)FDA LinkGeneric 02/2020 - 09/2019
2	MicellesIBA 11/2019 - 11/2018
2	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 01/2014
2	Polo-Like Kinase 1IBA 10/2019 - 11/2018
1	Biological ProductsIBA 06/2022
1	DEET (DET)IBA 01/2022
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2022
1	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 01/2022
1	baricitinibIBA 09/2021
1	edoxabanIBA 05/2021
1	binimetinibIBA 05/2021
1	encorafenibIBA 05/2021
1	fibrin fragment D (D-dimer)IBA 05/2021
1	trametinibIBA 05/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2021
1	dabrafenibIBA 05/2021
1	SulfurIBA 01/2021
1	polyornithineIBA 01/2021
1	Ribonuclease H (RNase H)IBA 10/2020
1	ChemokinesIBA 10/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2020
1	C-Reactive ProteinIBA 02/2020
1	Interleukin-22 (IL-22)IBA 02/2020
1	Cholecalciferol (Vitamin D3)FDA Link 02/2020
1	InterleukinsIBA 02/2020
1	calcipotriene (calcipotriol)FDA LinkGeneric 02/2020
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 02/2020
1	Thyroxine (Levothyroxine)FDA LinkGeneric 02/2020
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 02/2020
1	CytokinesIBA 02/2020
1	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 02/2020
1	Immunoglobulin E (IgE)IBA 01/2020
1	Infliximab (Remicade)FDA Link 01/2020
1	Antisense OligonucleotidesIBA 11/2019
1	Long Noncoding RNAIBA 11/2019
1	Lysine (L-Lysine)FDA Link 11/2019
1	poly(2-ethyl-2-oxazoline)IBA 11/2019
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 10/2019
1	AntibodiesIBA 09/2019
1	Interleukin-23 Subunit p19IBA 09/2019
1	Interleukin-17 (Interleukin 17)IBA 09/2019
1	Nucleic AcidsIBA 01/2019
1	OligonucleotidesIBA 01/2019
1	Bimatoprost (Lumigan)FDA Link 11/2018
1	ProstaglandinsIBA 11/2018
1	Immunoglobulin FragmentsIBA 11/2018
1	Thromboplastin (Tissue Factor)IBA 11/2018
1	tocilizumab (atlizumab)FDA Link 08/2018
1	Dipeptidyl-Peptidase IV InhibitorsIBA 05/2018
1	AutoantibodiesIBA 05/2018
1	EpitopesIBA 05/2018
1	Immunoglobulin G (IgG)IBA 04/2018
1	cyclic arginine-glycine-aspartic acid peptideIBA 12/2016
1	LigandsIBA 12/2016

Therapy/Procedure

5	Therapeutics 05/2021 - 01/2014
1	Blood Component Removal (Apheresis) 11/2022
1	Critical Care (Surgical Intensive Care) 06/2022
1	Intravenous Injections 01/2021
1	Infusion Pumps (Infusion Pump) 01/2021
1	Intravesical Administration 06/2019